Dr Hashmi on Real-World Teclistamab Use in Relapsed/Refractory Multiple Myeloma

Hamza Hashmi, MD, discusses a real-world study of the efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma.

Related Keywords

Hamza Hashmi ,University Of South Carolina Hollings Cancer Center ,Medical University ,South Carolina Hollings Cancer Center ,D ,Efficacy And Safety Of Teclistamab ,Patients With Relapsed Refractory Multiple Myeloma ,Medical University Of South Carolina Hollings Cancer Center ,